
AFFINITY ASSET ADVISORS, LLC
Latest 13F filing data - Q4 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | OVID | 7.15M | $11.65M |
![]() | VTYX | 6.48M | $58.56M |
![]() | ERAS | 3.90M | $14.51M |
![]() | TSHA | 3.30M | $18.15M |
![]() | LXEO | 3.20M | $31.78M |
![]() | SVRA | 2.80M | $16.87M |
![]() | WVE | 2.70M | $45.90M |
![]() | PRQR | 2.45M | $4.96M |
![]() | RZLT | 2.35M | $5.55M |
![]() | TRVI | 2.15M | $26.92M |
![]() | IBIO | 2.06M | $3.97M |
![]() | CGEM | 1.93M | $20.00M |
![]() | ZURA | 1.81M | $9.50M |
![]() | ROIV | 1.70M | $36.89M |
![]() | GERN | 1.50M | $1.98M |
![]() | SYRE | 1.43M | $46.93M |
![]() | TEVA | 1.40M | $43.69M |
![]() | XENE | 1.25M | $56.02M |
![]() | APGE | 1.23M | $93.21M |
![]() | SGMT | 1.15M | $6.80M |

Ovid Therapeutics Inc.
OVID
Shares Held
7.15M
Value
$11.65M

Ventyx Biosciences, Inc.
VTYX
Shares Held
6.48M
Value
$58.56M

Erasca, Inc.
ERAS
Shares Held
3.90M
Value
$14.51M

Taysha Gene Therapies, Inc.
TSHA
Shares Held
3.30M
Value
$18.15M

Lexeo Therapeutics, Inc. Common Stock
LXEO
Shares Held
3.20M
Value
$31.78M

Savara Inc.
SVRA
Shares Held
2.80M
Value
$16.87M

Wave Life Sciences Ltd.
WVE
Shares Held
2.70M
Value
$45.90M

ProQR Therapeutics N.V.
PRQR
Shares Held
2.45M
Value
$4.96M

Rezolute, Inc.
RZLT
Shares Held
2.35M
Value
$5.55M

Trevi Therapeutics, Inc.
TRVI
Shares Held
2.15M
Value
$26.92M

iBio, Inc.
IBIO
Shares Held
2.06M
Value
$3.97M

Cullinan Therapeutics, Inc.
CGEM
Shares Held
1.93M
Value
$20.00M

Zura Bio Limited
ZURA
Shares Held
1.81M
Value
$9.50M

Roivant Sciences Ltd.
ROIV
Shares Held
1.70M
Value
$36.89M

Geron Corporation
GERN
Shares Held
1.50M
Value
$1.98M

Spyre Therapeutics, Inc.
SYRE
Shares Held
1.43M
Value
$46.93M

Teva Pharmaceutical Industries Limited
TEVA
Shares Held
1.40M
Value
$43.69M

Xenon Pharmaceuticals Inc.
XENE
Shares Held
1.25M
Value
$56.02M

Apogee Therapeutics, Inc.
APGE
Shares Held
1.23M
Value
$93.21M

Sagimet Biosciences Inc.
SGMT
Shares Held
1.15M
Value
$6.80M
